Biochemically altered myelin triggers autoimmune demyelination
Author(s) -
Andrew V. Caprariello,
James A. Rogers,
Megan L. Morgan,
Vahid Hoghooghi,
Jason R. Plemel,
Adam Koebel,
Shigeki Tsutsui,
Jeff F. Dunn,
Lakshmi P. Kotra,
Shalina S. Ousman,
V. Wee Yong,
Peter K. Stys
Publication year - 2018
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1721115115
Subject(s) - myelin , multiple sclerosis , pathogenesis , axon , inflammation , demyelinating disorder , pathology , medicine , neuroscience , myelin sheath , immunology , central nervous system , biology
Significance Caprariello et al. demonstrate that subtle biochemical pathology to axon-ensheathing myelin, in the absence of overt demyelination, is sufficient to elicit severe secondary demyelinating inflammatory reactions. The resulting lesions bear radiological and histological resemblance to inflammatory demyelinating lesions of multiple sclerosis (MS), raising the possibility that subtle myelin degeneration in the MS brain may be a proximal event in the evolution of inflammation and consequent myelin loss. Consistent with an “inside-out” model of MS pathogenesis, these findings provide a rationale for investigating myelin as a target for early preventive therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom